Two Sigma Investments
HZNP

Two Sigma Investments’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Two Sigma Investments’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-16,100
Closed -$1.86M – 3480
2023
Q3 		$1.86M Sell
16,100
-89,300
-85% -$9.59M 0.01% 1445
2023
Q2 		$10.8M Buy
105,400
+73,100
+226% +$7.71M 0.03% 606
2023
Q1 		$3.53M Buy
32,300
+18,400
+132% +$2.03M 0.01% 1069
2022
Q4 		$1.58M Sell
13,900
-326,500
-96% -$27.1M 0.01% 1444
2022
Q3 		$21.1M Buy
+340,400
New +$23.8M 0.07% 313
2022
Q1 		– Sell
-4,386
Closed -$473K – 4812
2021
Q4 		$473K Buy
+4,386
New +$478K ﹤0.01% 3305
2021
Q2 		– Sell
-2,905
Closed -$267K – 4817
2021
Q1 		$267K Sell
2,905
-20,387
-88% -$1.72M ﹤0.01% 3420
2020
Q4 		$1.7M Sell
23,292
-423,991
-95% -$31.5M ﹤0.01% 1598
2020
Q3 		$34.7M Buy
447,283
+371,596
+491% +$25.6M 0.12% 168
2020
Q2 		$4.21M Buy
+75,687
New +$3.24M 0.02% 720
2020
Q1 		– Sell
-266,624
Closed -$9.65M – 4147
2019
Q4 		$9.65M Sell
266,624
-149,989
-36% -$4.6M 0.03% 637
2019
Q3 		$11.3M Sell
416,613
-418,050
-50% -$10.8M 0.04% 509
2019
Q2 		$20.1M Sell
834,663
-303,090
-27% -$7.69M 0.07% 352
2019
Q1 		$30.1M Sell
1,137,753
-625,835
-35% -$14.8M 0.1% 269
2018
Q4 		$34.5M Buy
1,763,588
+805,770
+84% +$15.8M 0.13% 200
2018
Q3 		$18.8M Buy
957,818
+192,267
+25% +$3.66M 0.05% 435
2018
Q2 		$12.7M Buy
765,551
+405,958
+113% +$6.19M 0.04% 567
2018
Q1 		$5.11M Sell
359,593
-150,195
-29% -$2.22M 0.02% 939
2017
Q4 		$7.44M Buy
+509,788
New +$7.16M 0.02% 717
2017
Q2 		– Sell
-58,397
Closed -$863K – 3447
2017
Q1 		$863K Buy
58,397
+39,246
+205% +$636K ﹤0.01% 2013
2016
Q4 		$310K Buy
+19,151
New +$347K ﹤0.01% 2739
2016
Q1 		– Sell
-186,349
Closed -$3.26M – 3273
2015
Q4 		$4.04M Buy
+186,349
New +$3.63M 0.02% 750
2015
Q3 		– Sell
-110,755
Closed -$3.85M – 2979
2015
Q2 		$3.85M Sell
110,755
-167,575
-60% -$5.11M 0.02% 843
2015
Q1 		$7.23M Buy
+278,330
New +$5.1M 0.03% 576
2014
Q2 		– Sell
-78,510
Closed -$1.19M – 2449
2014
Q1 		$1.19M Sell
78,510
-91,687
-54% -$1.04M 0.01% 1141
2013
Q4 		$1.3M Buy
170,197
+159,497
+1,491% +$860K 0.01% 1207
2013
Q3 		$36K Buy
+10,700
New +$28.2K ﹤0.01% 1790

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Two Sigma Investments's HZNP Position: Q4 2023 in Review

Two Sigma Investments sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 16,100 shares — an estimated $1.86M sold.

Two Sigma Investments first reported a position in HZNP in Q3 2013 and held it in 27 quarters. The position peaked at $34.7M in Q3 2020. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Two Sigma Investments reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Two Sigma Investments sold 16,100 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $1.86M.
  • Two Sigma Investments first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2013 and held it in 27 quarters.
  • Two Sigma Investments's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $34.7M in Q3 2020.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Two Sigma Investments's 13F filing for Q4 2023, filed 14 Feb 2024.